Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02477293
Other study ID # B120014
Secondary ID
Status Completed
Phase Phase 4
First received June 10, 2015
Last updated December 28, 2016
Start date August 2015
Est. completion date January 2016

Study information

Verified date December 2016
Source Kyung Hee University Hospital at Gangdong
Contact n/a
Is FDA regulated No
Health authority Korea: Ministry for Health and Welfare
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and effectiveness of Hyeonggaeyeongyo-Tang for chronic rhinitis according to pattern identification in Korean medicine.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria:

1. Patients who are diagnosed by moderate level of chronic rhinitis for more than 8 weeks

- At least one of the following conditions: Nasal congestion, rhinorrhea, sneeze, pruritus

- At least one of the following Moderate abnormality conditions: sleep disturbance; daily activity, physical exercise, leisure activity limitations; work/school work limitations; discomfort with several symptoms

2. Age between 19 and 65 years

3. Able to dialogue

4. Agree with informed consent

Exclusion Criteria:

1. Patients who are taken one of the following drugs for treating rhinitis or acute upper respiratory infections etc

- Drugs which determined to have negative effect on symptoms of rhinitis or skin prick test (oral or nasal)

- Short acting anti-histamines / H1 blockers (drug use within lase 1 week)

- Long acting anti-histamines / H1 blockers (drug use within lase 2 week)

- Corticosteroids (drug use within lase 1 month) ? Anti-cholinergic drug (drug use within lase 1 week)

- Anti-leukotriene drug (drug use within lase 1 week)

- Decongestants (drug use within lase 1 week) ? Tricyclic antidepressants, phenothiazines (drug use within lase 2 week) ? Non-steroidal analgesics (drug use within lase 1 week) ? Drugs that is judged to be inappropriate for the trial by the researchers

2. Used Korean medicine for treating rhinitis within last 7 days

3. Patients who has severe disease, such as malignant tumor, severe dyslipidemia, liver or kidney dysfunction, anemia, active pulmonary tuberculosis, infection or systemic disease etc

4. Presence of internal nasal obstruction or nasal deformities or history of nasal surgery within 2 months

5. History of active respiratory disease(ex. asthma)

6. Hypertension or Diabetes

7. Experienced immunotherapy or systemic steroid treatments within last 3 months

8. Experienced drug allergic reactions

9. Experienced anaphylactic reactions, during allergen test

10. Female patients who are pregnant or lactating or have the chances of pregnancy

11. Patients who are participated other clinical trials within last 1 month

12. Patients who are unable to participate the trial (paralysis, severe mental or psychological illness, dementia, drug addiction, unable to make to participate in the trial, severe visual or auditory dysfunction, unable to visit hospital regularly, unable to communicate through spoken or written Korean etc)

13. Patients who are judged to be inappropriate for the clinical study by the researchers

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Hyeonggaeyeongyo-tang


Locations

Country Name City State
Korea, Republic of Kyung Hee University Hospital at Gangdong Seoul

Sponsors (1)

Lead Sponsor Collaborator
Kyung Hee University Hospital at Gangdong

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Kim MH, Son J, Nam HJ, Ko SG, Choi I. Hyeonggaeyeongyo-Tang for Treatment of Allergic and Nonallergic Rhinitis: A Prospective, Nonrandomized, Pre-Post Study. Evid Based Complement Alternat Med. 2016;2016:9202675. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in 'Total nasal symptom score (TNSS)' At baseline, Day 2(Scheduled within a week of baseline), Week 3, 5, 9, 13 No
Primary Change from baseline in 'pre KiFDA-AR ver 2.0' Questionnaire At baseline, Day 2(Scheduled within a week of baseline), Week 3, 5, 9, 13 No
Secondary Pattern Diagnosis by 'Cold-heat Pattern Identification Questionnaire' Pattern Diagnosis(either cold or heat pattern) based on the results of Cold-heat Pattern Identification Questionnaire Day 2(Scheduled within a week of baseline) No
Secondary Change from baseline in 'Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)' At baseline, Day 2(Scheduled within a week of baseline), Week 3, 5, 9, 13 No
Secondary Pattern diagnosis by doctor of Korean medicine by traditional Korean medicine doctor's four examination Pattern Diagnosis(either wind-heat or wind-cold pattern) based on the results of traditional Korean medicine doctor's four examination(questioning/history taking, inspection, auscultation (listening) & olfaction (smelling), and palpation) Day 2(Scheduled within a week of baseline) No
Secondary Diagnosis of secondary complications of chronic rhinitis (allergic rhinitis) by skin prick test Observed the allergic reaction for assessing the allergenicity of patients with allergic rhinitis Day 2(Scheduled within a week of baseline) No
Secondary Change from baseline in total immunoglobulin E (IgE) Day 2(Scheduled within a week of baseline), Week 5 No
Secondary Change from baseline in 'Heart Rate Variability' Day 2(Scheduled within a week of baseline), Week 5 No
Secondary Change from Baseline in 'Ryodoraku values' Investigate the different changes on autonomic nervous system from Ryodoraku value. The 12 measured Ryodoraku points are 6 on the hand(represented as H) and 6 on the feet(represented as F). Day 2(Scheduled within a week of baseline), Week 5 No
Secondary Diagnosis of secondary complications of chronic rhinitis (allergic rhinitis and rhino-sinusitis) by Waters, Caldwell, and lateral view (paranasal sinus 3P) Day 2(Scheduled within a week of baseline) No
Secondary Change from baseline in 'Perceived Stress Scale' Day 2(Scheduled within a week of baseline), Week 5 No
Secondary Change from baseline in eosinophil count level Day 2(Scheduled within a week of baseline), Week 5 No
See also
  Status Clinical Trial Phase
Completed NCT02340130 - Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma Phase 2
Completed NCT02360072 - Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
Completed NCT01118312 - Study of Asthma and Nasal Steroids Phase 4
Completed NCT00762567 - Phenylephrine Pediatric Pharmacokinetic Study Phase 1
Completed NCT00541255 - A Long-Term Examination of Asthma From Childhood Through Adolescence
Completed NCT00279916 - Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays Phase 3
Completed NCT00524836 - Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis Phase 3
Completed NCT00963573 - Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) Phase 4
Completed NCT00521131 - Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites Phase 4
Completed NCT04132570 - A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution Phase 4
Completed NCT02784262 - Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis Phase 2
Completed NCT02596321 - A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma Phase 3
Terminated NCT02630472 - Topical Irrigation Therapy for CRS Phase 1/Phase 2
Completed NCT02279706 - Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test N/A
Completed NCT01971086 - Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary N/A
Completed NCT01771120 - Control and Burden of Asthma and Rhinitis N/A
Withdrawn NCT01177852 - Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis Phase 3
Completed NCT01469234 - A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) Phase 4
Completed NCT02879929 - Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction N/A
Completed NCT00724698 - Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria